Log In
Print this Print this

Subcutaneous rituximab (Subcutaneous MabThera)

Also known as: MabThera SC

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSubcutaneous formulation of rituximab, a chimeric mAb against CD20 antigen
Molecular Target CD20
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today